artemether, 71939-51-0

Articles:

PubMed:	Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria.
PubMed:	A comparative study on the impact of two artemisinin derivatives, artemether and artesunate, on the female reproductive system of Fasciola hepatica.
PubMed:	Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.
PubMed:	Integration of novel low-cost colorimetric, laser photometric, and visual fluorescent techniques for rapid identification of falsified medicines in resource-poor areas: application to artemether-lumefantrine.
PubMed:	Artemether-lumefantrine: an option for malaria.
PubMed:	Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
PubMed:	Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.
PubMed:	Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?
PubMed:	Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design.
PubMed:	Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.
PubMed:	Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine.
PubMed:	Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.
PubMed:	Monitoring of artemisinin, dihydroartemisinin, and artemether in environmental matrices using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS).
PubMed:	Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania.
PubMed:	The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
PubMed:	Rational dispensing and use of artemether-lumefantrine during pregnancy in Dar es Salaam, Tanzania.
PubMed:	Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers.
PubMed:	Changes in the visceral functions of Plasmodium berghei-infected and -uninfected rats following administration of artemether.
PubMed:	Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
PubMed:	Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy.
PubMed:	Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
PubMed:	First case of treatment failure of artemether-lumefantrine in a Japanese traveler with imported falciparum malaria.
PubMed:	Pharmacokinetic interaction trial between co-artemether and mefloquine.
PubMed:	The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects.
PubMed:	Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
PubMed:	Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
PubMed:	Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models.
PubMed:	Effect of artemether alone and in combination with grapefruit juice on hepatic drug-metabolising enzymes and biochemical aspects in experimental Schistosoma mansoni.
PubMed:	Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
PubMed:	Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
PubMed:	Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
PubMed:	Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
PubMed:	Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
PubMed:	The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.
PubMed:	Understanding the pharmacokinetics of Coartem.
PubMed:	Factors affecting availability of essential medicines among community health workers in Ethiopia, Malawi, and Rwanda: solving the last mile puzzle.
PubMed:	Experience With the Priority Review Voucher Program for Drug Development.
PubMed:	Studies of the neurotoxicity of oral artemisinin derivatives in mice.
PubMed:	A qualitative study of perceptions of a mass test and treat campaign in Southern Zambia and potential barriers to effectiveness.
PubMed:	Management of imported malaria in Europe.
PubMed:	Development of simplified HPLC methods for the detection of counterfeit antimalarials in resource-restraint environments.
PubMed:	Malaria: severe, life-threatening.
PubMed:	Awareness of anti-malarial policy and malaria treatment practices of patent medicine vendors in three Nigerian states.
PubMed:	Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.
PubMed:	Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
PubMed:	How much fat is necessary to optimize lumefantrine oral bioavailability?
PubMed:	[The treatment of falciparum malaria].
PubMed:	Artemisinin-based combination therapies for uncomplicated malaria.
PubMed:	First artemisinin-based antimalarial combination approved for U.S. market.
PubMed:	Artemisinins and synthetic trioxolanes in the treatment of helminth infections.
PubMed:	[Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
PubMed:	Antiparasitic agents.
PubMed:	Malaria: severe, life-threatening.
PubMed:	Malaria: uncomplicated, caused by Plasmodium falciparum.
PubMed:	Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses.
PubMed:	FDA launches priority vouchers for neglected-disease drugs.